Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM8 | O00222 | 1/20 | 0.54 |
| ▸ | GRM6 | O15303 | 1/20 | 0.54 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.54 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.54 |
| ▸ | GSR | P00390 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.54 |
| ▸ | GRM5 | P41594 | 1/20 | 0.54 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.54 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.54 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.54 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.54 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.54 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.54 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.54 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.54 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.54 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.54 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.54 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2909135 | 1.00 | GRM8 (0.54) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL8160588 | 0.98 | GRM8 (0.52) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL31562940 | 0.87 | GSR (0.62) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL28229088 | 0.83 | GSR (0.58) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL6445994 | 0.83 | KMT2A (0.53) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL27760617 | 0.82 | GRM8 (0.52) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL8176286 | 0.82 | GRM8 (0.47) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL7049981 | 0.82 | ALOX15 (0.59) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL27890690 | 0.82 | ALOX15 (0.59) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL3678707 | 0.80 | GSR (0.54) | GRM8GRM6GRIN2DGRIN3BGSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 389 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| US-20250354185-A1 | BLUE PIGMENT AND BIOSYNTHESIS METHOD THEREOF | VERTEXYN BIOWORKS CO LTD (CN) | 2025-11-20 | — | — | US | claimed |
| US-20250258146-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2025-08-14 | — | — | US | claimed |
| WO-2025068210-A2 | USE OF A MARKER SET FOR DETERMINING THE AGGRESSIVENESS OF A PROSTATE TUMOR | NUMARES AG (DE) | 2025-04-03 | — | — | WO | claimed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | claimed |
| WO-2025068209-A1 | USE OF A MARKER SET FOR DETERMINING THE RISK OF DEVELOPING CASTRATION-RESISTANT PROSTATE CANCER | NUMARES AG (DE) | 2025-04-03 | — | — | WO | claimed |
| CN-119385996-A | Application of N-acetylglutamine in product for preventing or treating ulcerative colitis and product | 南方医科大学深圳医院 | 2025-02-07 | — | — | CN | claimed |
| CN-118360308-B | Construction method and application of metabolic engineering bacteria for biosynthesis of N-acetyl cerulosa by using glutamic acid as substrate | 南京合谷生命生物科技有限公司 | 2024-09-27 | — | — | CN | claimed |
| CN-118184576-B | Natural blue pigment and biosynthesis method thereof | 南京合谷生命生物科技有限公司 | 2024-08-16 | — | — | CN | claimed |
| CN-118360308-A | Construction method and application of metabolic engineering bacteria for biosynthesis of N-acetyl cerulosa by using glutamic acid as substrate | 南京合谷生命生物科技有限公司 | 2024-07-19 | — | — | CN | claimed |
| EP-2024423-B1 | AMINO-ACID FUNCTIONAL SILOXANES, METHODS OF PREPARATION AND APPLICATIONS | DOW CORNING (US) | 2009-12-09 | — | — | EP | claimed |
| WO-2006086731-A2 | METHOD FOR IDENTIFYING THE RISK OF PRETERM DELIVERY | THE GOV'T.T OF THE USA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2006-08-17 | — | — | WO | claimed |
| US-20060029563-A1 | Cutanceous metabolic bio-activator | JEAN-NOEL THOREL (FR) | 2006-02-09 | — | — | US | claimed |
| US-6770758-B2 | USING CONJUGATING LIGAND TO A THERMO-SENSITIVE POLYMERS AND LIGAND SPECIFICALLY RECOGNIZES A POLYSACCHARIDE, AND THE THERMO-SENSITIVE POLYMER FEATURES A LOWER CRITICAL SOLUTION TEMPERATURE (LCST) | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2004-08-03 | — | — | US | claimed |
| US-20040127701-A1 | POLYSACCHARIDE SEPARATION METHOD | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE | 2004-07-01 | — | — | US | claimed |
| EP-0815833-B1 | Malodour preventing agents | GIVAUDAN SA (CH) | 2003-04-09 | — | — | EP | claimed |
| EP-0627410-B1 | N-ACYLGLUTAMINE DERIVATIVE | KYOWA HAKKO KOGYO KK (JP) | 1997-10-29 | — | — | EP | claimed |
| EP-0440058-B1 | Cosmetic composition | KYOWA HAKKO KOGYO KK (JP) | 1994-10-12 | — | — | EP | claimed |
| US-5112613-A | Enhanced moisture retention, skin care | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1992-05-12 | — | — | US | claimed |
| EP-0440058-A1 | Cosmetic composition | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1991-08-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040127701-A1 | POLYSACCHARIDE SEPARATION METHOD | ALG1, CSGALNACT1, STT3B | GRM8 2099/4885GRM6 1163/4885GRIN2D 3838/4885 |
| US-20250354185-A1 | BLUE PIGMENT AND BIOSYNTHESIS METHOD THEREOF | ASNS, GLUL, GALE | GRM8 1761/4885GRM6 1828/4885GRIN2D 724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.